Cargando…
Clinical and preclinical therapeutic outcome metrics for USH2A-related disease
USH2A variants are the most common cause of Usher syndrome type 2, characterized by congenital sensorineural hearing loss and retinitis pigmentosa (RP), and also contribute to autosomal recessive non-syndromic RP. Several treatment strategies are under development; however, sensitive clinical trial...
Autores principales: | Toms, Maria, Dubis, Adam M, de Vrieze, Erik, Tracey-White, Dhani, Mitsios, Andreas, Hayes, Matthew, Broekman, Sanne, Baxendale, Sarah, Utoomprurkporn, Nattawan, Bamiou, Doris, Bitner-Glindzicz, Maria, Webster, Andrew R, Van Wijk, Erwin, Moosajee, Mariya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7372554/ https://www.ncbi.nlm.nih.gov/pubmed/31998945 http://dx.doi.org/10.1093/hmg/ddaa004 |
Ejemplares similares
-
Investigating Biomarkers for USH2A Retinopathy Using Multimodal Retinal Imaging
por: Gill, Jasdeep S., et al.
Publicado: (2022) -
USH2A-retinopathy: From genetics to therapeutics
por: Toualbi, Lyes, et al.
Publicado: (2020) -
A protein domain-oriented approach to expand the opportunities of therapeutic exon skipping for USH2A-associated retinitis pigmentosa
por: Schellens, Renske T.W., et al.
Publicado: (2023) -
Phagosomal and mitochondrial alterations in RPE may contribute to KCNJ13 retinopathy
por: Toms, Maria, et al.
Publicado: (2019) -
Choroideremia: from genetic and clinical phenotyping to gene therapy and future treatments
por: Mitsios, Andreas, et al.
Publicado: (2018)